(NWPX) Northwest Pipe - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6677461013
Stock: Steel Pipe, Concrete Pipe, Water Systems, Infrastructure
Total Rating 70
Risk 87
Buy Signal 0.15
| Risk 5d forecast | |
|---|---|
| Volatility | 34.6% |
| Relative Tail Risk | -12.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.85 |
| Alpha | 64.25 |
| Character TTM | |
|---|---|
| Beta | 1.154 |
| Beta Downside | 0.498 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.36% |
| CAGR/Max DD | 0.72 |
EPS (Earnings per Share)
Revenue
Description: NWPX Northwest Pipe March 03, 2026
NWPX Infrastructure, Inc. manufactures water-related infrastructure products across North America, operating through two primary segments: Engineered Steel Pressure Pipe (SPP) and Precast Infrastructure and Engineered Systems. The SPP segment focuses on large-diameter, high-pressure steel pipeline systems essential for drinking water, hydroelectric power, and seismic resiliency applications. The Precast segment supplies stormwater and wastewater technologies, including reinforced concrete pipes, manholes, and biofiltration units under brands such as ParkUSA and Geneva Pipe.
As a supplier primarily to installation contractors, the company’s revenue cycle is closely tied to municipal capital improvement budgets and federal infrastructure spending aimed at modernizing aging water grids. Headquartered in Vancouver, Washington, the firm was founded in 1966 and rebranded from Northwest Pipe Company in 2025. Investors reviewing sector-specific efficiency ratios can find additional data on ValueRay.
Headlines to watch out for
- Infrastructure spending drives steel pipe demand
- Raw material costs impact manufacturing margins
- Water infrastructure projects fuel precast product sales
- Regulatory changes affect pipeline construction
- Interest rates influence municipal project financing
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 35.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.32 > 1.0 |
| NWC/Revenue: 35.15% < 20% (prev 38.04%; Δ -2.89% < -1%) |
| CFO/TA 0.12 > 3% & CFO 67.3m > Net Income 35.4m |
| Net Debt (107.7m) to EBITDA (68.8m): 1.56 < 3 |
| Current Ratio: 3.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (9.80m) vs 12m ago -3.03% < -2% |
| Gross Margin: 19.70% > 18% (prev 0.19%; Δ 1951 % > 0.5%) |
| Asset Turnover: 89.97% > 50% (prev 83.53%; Δ 6.44% > 0%) |
| Interest Coverage Ratio: 7.32 > 6 (EBITDA TTM 68.8m / Interest Expense TTM 7.36m) |
Altman Z'' 5.90
| A: 0.32 (Total Current Assets 251.4m - Total Current Liabilities 66.5m) / Total Assets 579.6m |
| B: 0.49 (Retained Earnings 281.7m / Total Assets 579.6m) |
| C: 0.09 (EBIT TTM 53.8m / Avg Total Assets 584.6m) |
| D: 1.52 (Book Value of Equity 281.7m / Total Liabilities 184.8m) |
| Altman-Z'' Score: 5.90 = AAA |
Beneish M -3.54
| DSRI: 0.43 (Receivables 78.2m/170.4m, Revenue 526.0m/492.5m) |
| GMI: 0.98 (GM 19.70% / 19.37%) |
| AQI: 0.96 (AQ_t 0.14 / AQ_t-1 0.15) |
| SGI: 1.07 (Revenue 526.0m / 492.5m) |
| TATA: -0.05 (NI 35.4m - CFO 67.3m) / TA 579.6m) |
| Beneish M-Score: -3.54 (Cap -4..+1) = AAA |
What is the price of NWPX shares?
As of March 11, 2026, the stock is trading at USD 75.76 with a total of 136,172 shares traded.
Over the past week, the price has changed by -6.42%, over one month by +0.50%, over three months by +25.14% and over the past year by +89.07%.
Over the past week, the price has changed by -6.42%, over one month by +0.50%, over three months by +25.14% and over the past year by +89.07%.
Is NWPX a buy, sell or hold?
Northwest Pipe has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy NWPX.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NWPX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 86 | 13.5% |
| Analysts Target Price | 86 | 13.5% |
NWPX Fundamental Data Overview March 09, 2026
P/E Trailing = 21.1601
P/E Forward = 18.7266
P/S = 1.3762
P/B = 1.8269
P/EG = 1.7035
Revenue TTM = 526.0m USD
EBIT TTM = 53.8m USD
EBITDA TTM = 68.8m USD
Long Term Debt = 8.76m USD (from longTermDebt, last quarter)
Short Term Debt = 9.92m USD (from shortTermDebt, last quarter)
Debt = 109.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 107.7m USD (from netDebt column, last quarter)
Enterprise Value = 831.5m USD (723.9m + Debt 109.9m - CCE 2.27m)
Interest Coverage Ratio = 7.32 (Ebit TTM 53.8m / Interest Expense TTM 7.36m)
EV/FCF = 17.65x (Enterprise Value 831.5m / FCF TTM 47.1m)
FCF Yield = 5.66% (FCF TTM 47.1m / Enterprise Value 831.5m)
FCF Margin = 8.96% (FCF TTM 47.1m / Revenue TTM 526.0m)
Net Margin = 6.73% (Net Income TTM 35.4m / Revenue TTM 526.0m)
Gross Margin = 19.70% ((Revenue TTM 526.0m - Cost of Revenue TTM 422.4m) / Revenue TTM)
Gross Margin QoQ = 21.30% (prev 21.28%)
Tobins Q-Ratio = 1.43 (Enterprise Value 831.5m / Total Assets 579.6m)
Interest Expense / Debt = 2.16% (Interest Expense 2.37m / Debt 109.9m)
Taxrate = 17.76% (1.92m / 10.8m)
NOPAT = 44.3m (EBIT 53.8m * (1 - 17.76%))
Current Ratio = 3.78 (Total Current Assets 251.4m / Total Current Liabilities 66.5m)
Debt / Equity = 0.28 (Debt 109.9m / totalStockholderEquity, last quarter 394.8m)
Debt / EBITDA = 1.56 (Net Debt 107.7m / EBITDA 68.8m)
Debt / FCF = 2.29 (Net Debt 107.7m / FCF TTM 47.1m)
Total Stockholder Equity = 384.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.06% (Net Income 35.4m / Total Assets 579.6m)
RoE = 9.20% (Net Income TTM 35.4m / Total Stockholder Equity 384.8m)
RoCE = 13.68% (EBIT 53.8m / Capital Employed (Equity 384.8m + L.T.Debt 8.76m))
RoIC = 10.58% (NOPAT 44.3m / Invested Capital 418.4m)
WACC = 9.06% (E(723.9m)/V(833.8m) * Re(10.17%) + D(109.9m)/V(833.8m) * Rd(2.16%) * (1-Tc(0.18)))
Discount Rate = 10.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.51%
[DCF] Terminal Value 65.55% ; FCFF base≈42.0m ; Y1≈27.5m ; Y5≈12.6m
[DCF] Fair Price = 10.42 (EV 207.5m - Net Debt 107.7m = Equity 99.8m / Shares 9.57m; r=9.06% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 27.63 | EPS CAGR: 23.61% | SUE: 2.31 | # QB: 2
Revenue Correlation: 63.06 | Revenue CAGR: 3.78% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.24 | Chg7d=+0.015 | Chg30d=+0.015 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=4.20 | Chg7d=+0.358 | Chg30d=+0.372 | Revisions Net=+1 | Growth EPS=+16.9% | Growth Revenue=+3.7%
EPS next Year (2027-12-31): EPS=4.99 | Chg7d=+0.658 | Chg30d=+0.702 | Revisions Net=+2 | Growth EPS=+18.8% | Growth Revenue=+4.5%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 10.2% - Earnings Yield 4.7%)
[Growth] Growth Spread = +4.4% (Analyst 9.8% - Implied 5.4%)
P/E Forward = 18.7266
P/S = 1.3762
P/B = 1.8269
P/EG = 1.7035
Revenue TTM = 526.0m USD
EBIT TTM = 53.8m USD
EBITDA TTM = 68.8m USD
Long Term Debt = 8.76m USD (from longTermDebt, last quarter)
Short Term Debt = 9.92m USD (from shortTermDebt, last quarter)
Debt = 109.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 107.7m USD (from netDebt column, last quarter)
Enterprise Value = 831.5m USD (723.9m + Debt 109.9m - CCE 2.27m)
Interest Coverage Ratio = 7.32 (Ebit TTM 53.8m / Interest Expense TTM 7.36m)
EV/FCF = 17.65x (Enterprise Value 831.5m / FCF TTM 47.1m)
FCF Yield = 5.66% (FCF TTM 47.1m / Enterprise Value 831.5m)
FCF Margin = 8.96% (FCF TTM 47.1m / Revenue TTM 526.0m)
Net Margin = 6.73% (Net Income TTM 35.4m / Revenue TTM 526.0m)
Gross Margin = 19.70% ((Revenue TTM 526.0m - Cost of Revenue TTM 422.4m) / Revenue TTM)
Gross Margin QoQ = 21.30% (prev 21.28%)
Tobins Q-Ratio = 1.43 (Enterprise Value 831.5m / Total Assets 579.6m)
Interest Expense / Debt = 2.16% (Interest Expense 2.37m / Debt 109.9m)
Taxrate = 17.76% (1.92m / 10.8m)
NOPAT = 44.3m (EBIT 53.8m * (1 - 17.76%))
Current Ratio = 3.78 (Total Current Assets 251.4m / Total Current Liabilities 66.5m)
Debt / Equity = 0.28 (Debt 109.9m / totalStockholderEquity, last quarter 394.8m)
Debt / EBITDA = 1.56 (Net Debt 107.7m / EBITDA 68.8m)
Debt / FCF = 2.29 (Net Debt 107.7m / FCF TTM 47.1m)
Total Stockholder Equity = 384.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.06% (Net Income 35.4m / Total Assets 579.6m)
RoE = 9.20% (Net Income TTM 35.4m / Total Stockholder Equity 384.8m)
RoCE = 13.68% (EBIT 53.8m / Capital Employed (Equity 384.8m + L.T.Debt 8.76m))
RoIC = 10.58% (NOPAT 44.3m / Invested Capital 418.4m)
WACC = 9.06% (E(723.9m)/V(833.8m) * Re(10.17%) + D(109.9m)/V(833.8m) * Rd(2.16%) * (1-Tc(0.18)))
Discount Rate = 10.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.51%
[DCF] Terminal Value 65.55% ; FCFF base≈42.0m ; Y1≈27.5m ; Y5≈12.6m
[DCF] Fair Price = 10.42 (EV 207.5m - Net Debt 107.7m = Equity 99.8m / Shares 9.57m; r=9.06% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 27.63 | EPS CAGR: 23.61% | SUE: 2.31 | # QB: 2
Revenue Correlation: 63.06 | Revenue CAGR: 3.78% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.24 | Chg7d=+0.015 | Chg30d=+0.015 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=4.20 | Chg7d=+0.358 | Chg30d=+0.372 | Revisions Net=+1 | Growth EPS=+16.9% | Growth Revenue=+3.7%
EPS next Year (2027-12-31): EPS=4.99 | Chg7d=+0.658 | Chg30d=+0.702 | Revisions Net=+2 | Growth EPS=+18.8% | Growth Revenue=+4.5%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 10.2% - Earnings Yield 4.7%)
[Growth] Growth Spread = +4.4% (Analyst 9.8% - Implied 5.4%)